Showing results (331-340 of 502) with videos related to

Sort By:
Pageof 51
Biochimica Et Biophysica Acta|September 14, 1982
High content of 22:6 (docosahexaenoate) and active [2-3H]glycerol metabolism of phosphatidic acid from photoreceptor membranesN G Bazan, M Silvia di Fazio de Escalante, M M Careaga, et al.
Annals of Surgical Oncology|June 8, 2022
Modified Radical Mastectomy in De Novo Stage IV Inflammatory Breast CancerJ C Chen, Yaming Li, James L Fisher, et al.
NPJ Breast Cancer|March 26, 2021
De-escalation of radiation therapy in patients with stage I, node-negative, HER2-positive breast cancerJose G Bazan, Sachin R Jhawar, Daniel Stover, et al.
Plos One|January 20, 2011
Docosahexaenoic acid-derived neuroprotectin D1 induces neuronal survival via secretase- and PPARγ-mediated mechanisms in Alzheimer's disease modelsYuhai Zhao, Frederic Calon, Carl Julien, et al.
Translational Stroke Research|March 23, 2011
Docosahexaenoic Acid therapy of experimental ischemic strokeLudmila Belayev, Larissa Khoutorova, Kristal D Atkins, et al.
Neurochemical Research|April 1, 1994
The effect of a free radical scavenger and platelet-activating factor antagonist on FFA accumulation in post-ischemic canine brainD Sun, D Kintner, J H Fitzpatrick, et al.
Communications Biology|April 10, 2026
Elovanoid neuroprotection targets cell transcriptomics and proteomics to sustain synaptic integrity after brain injuryBrian L Giles, Surjyadipta Bhattacharjee, Jeff X Ji, et al.
American Journal of Ophthalmology|December 15, 1990
Immunohistologic study of epiretinal membranes in proliferative vitreoretinopathyC Baudouin, D Fredj-Reygrobellet, W C Gordon, et al.
Journal of Neurochemistry|January 1, 1991
Recovery of postischemic brain metabolism and function following treatment with a free radical scavenger and platelet-activating factor antagonistsD D Gilboe, D Kintner, J H Fitzpatrick, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 23, 2025
ELV-N34, RvD6-Isomer, or NPD1 Halt Replication of SARS-CoV-2 Omicron BA.5 Virus in Human Lung and Nasal CellsJorgelina M Calandria, Haydee E P Bazan, Surjyadipta Bhattacharjee, et al.
Pageof 51